Universal Health Services (NYSE:UHS) Downgraded to Hold Rating by Wall Street Zen

Key Points

• Wall Street Zen downgraded Universal Health Services (UHS) from "buy" to "hold," and several other firms have trimmed price targets — the consensus rating is now "Hold" with an average price target of $220.94.
• UHS beat Q1 estimates (EPS $5.62 vs. $5.41; revenue $4.50B vs. $4.39B) and set FY2026 guidance of 22.640–24.520 EPS, but shares fell as investors focused on softer patient volumes and a cautious tone from management.
• Institutional ownership is high at 86.05%, with major funds (Pzena, Dimensional, Morgan Stanley, Norges Bank) materially increasing or establishing positions, signaling significant institutional interest despite near‑term uncertainty.

Universal Health Services (NYSE:UHS - Get Free Report) was downgraded by Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued to investors on Saturday.

Several other equities research analysts also recently weighed in on UHS. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Universal Health Services from $261.00 to $230.00 and set a "buy" rating on the stock in a research note on Wednesday. Stephens cut their price target on shares of Universal Health Services from $235.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday. Wells Fargo & Company cut their price target on shares of Universal Health Services from $235.00 to $212.00 and set an "equal weight" rating on the stock in a report on Monday, March 2nd. Barclays cut their price target on shares of Universal Health Services from $268.00 to $238.00 and set an "overweight" rating on the stock in a report on Tuesday. Finally, TD Cowen cut their price target on shares of Universal Health Services from $245.00 to $230.00 and set a "buy" rating on the stock in a report on Wednesday. Six investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Universal Health Services presently has an average rating of "Hold" and an average price target of $220.94.

Universal Health Services Trading Down 0.7%

Shares of UHS opened at $167.16 on Friday. Universal Health Services has a twelve month low of $152.33 and a twelve month high of $246.32. The company has a market cap of $10.21 billion, a P/E ratio of 6.97, a P/E/G ratio of 0.72 and a beta of 1.13. The company has a current ratio of 1.08, a quick ratio of 0.98 and a debt-to-equity ratio of 0.52. The company's fifty day simple moving average is $188.99 and its 200-day simple moving average is $208.93.

Universal Health Services (NYSE:UHS - Get Free Report) last announced its earnings results on Monday, April 27th. The health services provider reported $5.62 earnings per share for the quarter, beating the consensus estimate of $5.41 by $0.21. Universal Health Services had a net margin of 8.56% and a return on equity of 19.57%. The business had revenue of $4.50 billion for the quarter, compared to the consensus estimate of $4.39 billion. During the same quarter in the prior year, the firm posted $4.84 earnings per share. The business's revenue for the quarter was up 9.6% on a year-over-year basis. Universal Health Services has set its FY 2026 guidance at 22.640-24.520 EPS. As a group, analysts expect that Universal Health Services will post 23.34 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Pzena Investment Management LLC grew its holdings in Universal Health Services by 31.5% during the 4th quarter. Pzena Investment Management LLC now owns 2,112,604 shares of the health services provider's stock worth $460,590,000 after acquiring an additional 505,575 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Universal Health Services by 6.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,588,911 shares of the health services provider's stock worth $346,447,000 after acquiring an additional 94,447 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in Universal Health Services by 7.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,206,000 shares of the health services provider's stock worth $262,932,000 after acquiring an additional 80,236 shares in the last quarter. Norges Bank bought a new position in Universal Health Services during the 4th quarter worth about $199,334,000. Finally, Morgan Stanley grew its holdings in Universal Health Services by 59.5% during the 4th quarter. Morgan Stanley now owns 871,377 shares of the health services provider's stock worth $189,978,000 after acquiring an additional 325,162 shares in the last quarter. 86.05% of the stock is currently owned by institutional investors.

Key Universal Health Services News

Here are the key news stories impacting Universal Health Services this week:

• Positive Sentiment: UHS reiterated its full‑year 2026 volume targets despite softer seasonal volumes in Q1, signaling management confidence in recovery and that the Q1 hit may be temporary. Investors may view this as a stabilizing sign for guidance. UHS reaffirms 2026 volume targets
• Positive Sentiment: UHS deployed eight AI solutions in its revenue cycle in 2025 and is evaluating clinical operation use — potential margin upside and efficiency gains if rollouts scale. This supports longer‑term operating leverage. UHS deployed 8 AI solutions
• Neutral Sentiment: UHS is scheduled to present at the BofA Securities Health Care Conference (May 12). Management comments there could move shares if they provide clearer color on volumes, margins or M&A. UHS to present at BofA conference
• Neutral Sentiment: Analysts’ views are mixed on UHS relative to peers — differing takes may sustain volatility as investors parse which franchises (behavioral, acute, outpatient) will drive recovery. Analysts’ opinions mixed
• Negative Sentiment: Despite beating Q1 estimates, UHS shares fell after the quarter as investors focused on volume softness and the tone from the call rather than the beat — short‑term sentiment hurt. Why UHS is down after Q1
• Negative Sentiment: Coverage updates trimmed price targets: Stephens and Morgan Stanley lowered targets and kept “equal weight,” while several firms lowered targets (Mizuho, TD Cowen) even if ratings were maintained. Those revisions pressure sentiment and cap near‑term upside. Stephens price target cut Morgan Stanley price target cut
• Negative Sentiment: Q1 commentary/coverage noting that earnings growth was dampened by volume hits underscores the risk that patient volumes — not just pricing or cost control — will determine near‑term results. Q1 growth dampened by volume hits

Universal Health Services Company Profile

Universal Health Services, Inc NYSE: UHS is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS's facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.